the Thanks, to ability pleased and have on Good results record I'm our strategy. Max. execute in report everyone. our markets capabilities the on validating opportunity afternoon delivered our we based to target we
We would are about I by impacted my share is Before and war news disturbed watch everyone like a the I begin now. prepared our all and for happening remarks, what right Ukraine. concern take moment the to in
results. brought peaceful as this are with war to top-line Our can our hope and start with would soon be as this conflict possible. thoughts I conclusion by a like affected financial everyone that to
based in we mostly in basis, year services government XXXX beyond. increasing communicated the Full full driven forma XXXX revenue and growth as $XX.X continued a additional second Full Coming earlier our and XXXX the the was we year million, meaningful were both our which These to year-over-year was On half year fourth in growth. largely XXXX, positions $X.X by business. flat us state on a forma state million our a accelerating service from XXXX. number top We pro XX% year a $XX.X into pro XXXX one-time backlog, which results and of basis $X.X growth at grow million, by XX. full $XXX,XXX delivered was business. upon have QX growth business XX% XXXX, agreement items. prior software XXXX was well. of The and forma XXXX support to awarded X the from XXXX contracts year, to the the our from up in in million, trace track in were quarterly and was basis $XX.X revenue installation as information well revenue end compared want year-over-year. can information healthcare the in XXXX and which XXXX contracted on guidance revenue pro this Florida business, Forian of up million driven and $XXX,XXX XXXX revenue our fluctuate year. quarter revenue recently as We for was
by our are set non-GAAP measure XXXX reconciliation and negative directly as Additionally, we and million million. multiple just GAAP loss was was the financial I was quarter our net most net release and non-GAAP million quarter $X.X wins negative win XXXX million. and measure forth comparable SEC XXX% and this was perspective, full-year an Further Full-year fourth positioned the loss by well mentioned. measure financial $X.X presentation. the $XX.X U.S. defined have fourth a RFPs to is and as Adjusted rules. adjusted we EBITDA are to earnings where in our the regarding $XX.X to recent EBITDA From financial renewal measure responding information XXXX are evidenced of non-GAAP rate
in invest to product and innovation. continue talent key We both
half platform, focus data factory product sales. investment execute data initiated plan SaaS We improvements half see in result with and peaking in half additional loss lower investments healthcare We XXXX. data in second of have growth analytics, information added and of strong our These We our healthcare positions a engineering, information continue science XXXX XXXX into first the science product, in XXXX adjusted capabilities. of to our as the Catalytics expenses products. expected in will of in first EBITDA top-line and the
and expect to of provide that minutes adjusted the to we value We take to who half positive with I strong a our we revenue will customers. growth, second wanted we achieve continued EBITDA few in are the review XXXX.
growth the at XXXX. operations in business revenue our we we and in provider enabling Forian cannabis and track marketplace. in of software applications expect This cannabis the in ever our and compliance XXXX, number healthcare maintaining continue By software, our is capitalized convergence an industries. changing and evidenced by of of dynamic two will customers top-line trace truly which a provide success position software well and sitting analytics impressive commercial data the point-of-sale and innovative is
of compliant untapped cannabis software retail the information and retail to with with expertise, transactions. clinical of over database domain and leverage commercial annual claims over transaction to a the hundred industries. with new coupled Forian cannabis was an billion has cannabis develop analytics million capabilities rich a expertise the and healthcare, One allowed X.X in updated primary reasons BioTrack we prescription data interoperable The analytics power asset consummated HIPAA and and healthcare significant datasets cannabis billion containing weekly and both transaction for medical claims in over XX to integrated
enabled a are by science. We data driven company and product information
in provide the majority treatments patients. For population. hospital, and the being based into We therapeutics, healthcare sight the clinical doctor's are has commercial prescriptions science for the what U.S. of life upon what Forian traditional administered customers are being healthcare timely a covers and in of with office and that line insights data prescribed
As scale cannabis into consumer it will insight patient we how our databases, we and and journey. consumption impacts more the have
By is of being products are spans derivative purchased profiles, for from other customer we how attributes adults and information and heightened what as power assets. of power dispensaries the manufactured, exponentially cannabis nature as grown, of segments. branded integrated understanding incomes, consumer the volume of being at lifestyle more Forian's brings even information, by majority household also offering. attributes database U.S. have Forian consumer, race, and products to containing information the a understanding and an that chemical and being demographic and specific predictive and data their flower We've important packaged analytics well psychographic explanatory what gender,
standards attributes understanding are recreational analytic product is we Additionally, spoke a the payers. use products. of portfolio sensitivities and of of lens or affect focused that that that they traditional outcome of and pathways what may patient and and and earlier by consumers the the use reported is are products, price power the The based patient integrated view clients questions alternative and I an perspectives analytics same are studies, journey interventions, that degree de-identified of patient to we performing into patient alternative we of unique answer innovative. healthcare important XXX to what first about can can patients commercial cannabinoid care trial one choice consumer safety commercial analytics. support these product of and beliefs, in kind. the observations outcomes, how and the of are the its or By what and our the landscape understand therapeutics example and The therapeutics, market, impact serve. insight making both both as the data were offers is therapeutics, believe We available for traditional are cost consumer specific This treatment attitudes, clinical the important care case data investment of growing the drive one and continuum behavior. and be from frame industries approaches the such competitive about whether asset interoperable outcomes
our customers service. at better past retail have customer licenses years. are bringing year and in not issued software the Cannabis been to more same pace functionality in investing features user as and with We last the our experience over business, a
licenses as this use year and grow into expansion business. number regulate However, cannabis, providing to in opportunity our growth states software the or expect of granted for we of medical the XXXX later adult
services. to e-commerce, development delivery The services forth scale important was the and initial with platform as enable other and offers they XXXX back their technology Forian an to platforms This of API our information share investment that serve customers in environment marketing provider API better will businesses. started
of to are from launch and and see and insights is products. starting important the unit cannabis based our provides to platform, early analytics which volume Catalytics SaaS sales business which tracking, into We understand healthcare clients our receptivity
on With the occurring. certain the consumer answer we question integration of healthcare, why the market information, cannabis begin dynamics and are to
our to recommendations to assist sales marketing Our our them embedded with customers overall analytics and performance. acquiring drive advanced these driven retaining capability, segmentation provide as in capabilities customers into data such science and data
stated earlier, value for for evidence our From demonstrate driving answer the start early I product Forian real portfolio. integrated provide as Our patients. as is significant inform opportunities, of questions, product analytics information we're access well expanding we insights portfolio, R&D product stages and expedite data business critical commercial development, world to as and advanced growth commercialization, through accelerate and investment solutions,
network, and analysis therapeutic of analysis. or comprehensive added stability to evidence perform to source interventions Additionally, as million a standalone Closed patients. clinical data data we particular patients subset data all this a factory covering on about a asset network a patient enabling of complete real closed more which world both the our enhanced assets and XX integrated based journey payer studies network in data lives, capture significant provides more
around prescriber market analysis. information products journey, typically of are dynamics and payer four Our need clients patient our categories, answer segmentation, one which
insights allow care. For therapeutic of treatment example, drug, centered class, and of identification patient longitudinal behavior geography, patient by Then time, across Forian points level for facility spectrum the our or provides products focusing engagement actionable types. physician key and demographics around the payer, data
seamless expansion to and retained the of our trace We awarded in track the winning trace business were expanded Mexico, portal New award. the is with a we and in to states and Connecticut new all has find our In no with State and interoperability software, and are to diversion employing award early and New product of clients more renewal expansion of BioTrack benefit many ensure services track a ensure as services. trace markets. adult XXXX, state our new there business important point-of--sales a use on the Virginia have business point-of-sale expansion is York, business commercial and that to black State year well. Based utilize in trace extension Florida BioTrack and our track track software regulations also experience into business. compliance Hawaii, patient
products. analytics. or is This view products standard critical national the and system of no have product industry. the for ID ontology a standard for out data a useful provides accurate last in complete making ontology We nomenclature exists This building in step invested and classification over where year across cannabinoid cannabis system a more
as commercial performance. clean, sources now of and data and disparate Additionally, data dirty driving in normalized, we use can clinical provide and better a for to standardized service operational, aggregate
to Forian's on XXXX unstructured performance integrates NASDAQ. the unmet proprietary revenue information well which business and position are this with successfully of by a with cutting our data. edge results complex was continued has successfully and grew We for demonstrated We billion believe data the combine point-of-sale in Helix productive year our we and states technology invested create gross second and year summary, transactional XXXX in sitting we processing listed showed awarded ontology, and unusable organizes of merchandise the markets. value company systems functionality non-standard time and million. emerged are in market. thousands with of XXXX. and previously industry science and track We million data and position most reduces number cannabis trace our $XX.X are that our leading momentum can in We XXXX one cannabis revenue our operated service maintaining services efficiently in strong the full for data sets. employees. companies in structured We managing the serve we analytics in services mentioned complex, cannabis to into for and cost When we're our we XXXX Forian common and by two were $X.X to $XX of in new to over science our and needs information, In customers better a retain top-line growth capabilities and coming positioned providing Based regulatory market. XXXX, on guidance Forian and
to our expect We spending investment the first half in peak of XXXX.
continued positive investment second in will half the combination also XXXX adjusted provide and of will to CFO, revenue Vesey, XXXX growth over half Mike reduced the We and EBITDA adjusted the XXXX on the second of improved in sometime to results. XXXX. full turn financial detail of during the now expect quarter our fourth second spending of it starting more lead to half to turning in I our performance EBITDA XXXX year
